Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CPT2 | P23786 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ACLY | P53396 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL156918 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL27493653 | 1.00 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL6877372 | 0.98 | CYP2C19 (0.39) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL28843245 | 0.98 | CYP2C19 (0.39) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Water SCHEMBL7198408 | 0.98 | CYP2C19 (0.39) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL284431 | 0.98 | CYP2C19 (0.42) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Acetic Acid SCHEMBL15573268 | 0.95 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL21048439 | 0.95 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| Acetone SCHEMBL9653544 | 0.95 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 | |
| SCHEMBL28960526 | 0.95 | CYP2C19 (0.41) | CYP2C19HIF1ACYP2D6TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117990898-A | High-sensitivity and ultra-stable ELISA single-component color developing agent and stop solution | 禾旭(郑州)生物技术有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-114790472-B | Fructosyl curcumin, preparation method and application | 上海龙殷生物科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-8114959-B2 | Increasing the shelf-life of bulk glucagon-like peptide by treating a solution or suspension with a pharmaceutical buffer (TRIS) and preservative (phenol) to raise the pH to 8.5-9.6; freeze drying; regeneration; injections/biological/ | NOVO NORDISK A/S (DK) | 2012-02-14 | — | — | US | claimed |
| EP-1633390-B1 | STABILIZED PHARMACEUTICAL GLP-1 PEPTIDE COMPOSITIONS | NOVO NORDISK AS (DK) | 2012-01-18 | — | — | EP | claimed |
| EP-1633391-B1 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | NOVO NORDISK AS (DK) | 2011-10-19 | — | — | EP | claimed |
| US-7632806-B2 | Stabilized pharmaceutical peptide compositions | NOVO NORDISK A/S (DK) | 2009-12-15 | — | — | US | claimed |
| US-7595293-B2 | Stable pharmaceutical compositions | NOVO NORDISK A/S (DK) | 2009-09-29 | — | — | US | claimed |
| US-20080318865-A1 | Increasing the shelf-life of bulk glucagon-like peptide by treating a solution or suspension with a pharmaceutical buffer (TRIS) and preservative (phenol) to raise the pH to 8.5-9.6; freeze drying; regeneration; injections/biological/ | NOVO NORDISK A/S (DK) | 2008-12-25 | — | — | US | claimed |
| US-20060183682-A1 | Stabilized pharmaceutical peptide compositions | NOVO NORDISK A/S (DK) | 2006-08-17 | — | — | US | claimed |
| US-20060178304-A1 | Stabilized pharmaceutical peptide compositions | NOVO NORDISK A/S (DK) | 2006-08-10 | — | — | US | claimed |
| US-20060084605-A1 | Stable pharmaceutical compositions | NOVO NORDISK A/S (DK) | 2006-04-20 | — | — | US | claimed |
| EP-1633390-A2 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | NOVO NORDISK A/S (DK) | 2006-03-15 | — | — | EP | claimed |
| EP-1633391-A1 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | NOVO NORDISK A/S (DK) | 2006-03-15 | — | — | EP | claimed |
| WO-2004105790-A1 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | NOVO NORDISK A/S (DK) | 2004-12-09 | — | — | WO | claimed |
| WO-2004105781-A2 | STABILIZED PHARMACEUTICAL PEPTIDE COMPOSITIONS | NOVO NORDISK A/S (DK) | 2004-12-09 | — | — | WO | claimed |
| WO-2004089985-A1 | STABLE PHARMACEUTICAL COMPOSITIONS | NOVO NORDISK A/S (DK) | 2004-10-21 | — | — | WO | claimed |
| CN-117990898-A | High-sensitivity and ultra-stable ELISA single-component color developing agent and stop solution | 禾旭(郑州)生物技术有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-114790472-B | Fructosyl curcumin, preparation method and application | 上海龙殷生物科技有限公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-0712632-A1 | REMEDY FOR DISEASES CHARACTERIZED BY ABNORMAL ACCUMULATION OR ACTIVATION OF LEUKOCYTE | TORAY INDUSTRIES, INC. (JP) | 1996-05-22 | — | — | EP | disclosed |
| US-5159096-A | In presence of at lease one sodium hydrogen phosphate | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1992-10-27 | — | — | US | disclosed |